A-Z Index
Image Cart
              

 Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members


Revision Bulletin

Felodipine Extended-Release Tablets

Posting Date: 29 September 2009
Official Date: 1 November 2009
Expert Committee: Biopharmaceutics


In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the Felodipine Extended-Release Tablets monograph by the inclusion of a Dissolution Test 3 for a new generic version of Felodipine Extended-Release Tablets recently approved by the Food and Drug Administration.

The Felodipine Extended Release Tablets Revision Bulletin supersedes the monograph in USP 32-NF 27 until it is printed in the USP 33–NF 28 First Supplement which will be released 1 February 2010 and becomes official 1 August 2010.

Should you have any questions, please contact Margareth Marques, Ph.D. (301-816-8106 or ().

Download the Felodipine Extended-Release Tablets Revision Bulletin  (749KB).

What's New

Changes to the Dissolution Performance Verification Test (11/20/09)

PF 35(6) Errata (10/30/09)

New official Text for October: 15 Revisions Bulletins (10/30/09)

Pending Standards for the month of October (10/30/09)

PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09)

Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09)

Elemental Impurities Hot Topics information updated (10/13/09)

General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09)

Heparin Hot Topics information updated (10/02/09)

PF Redesign

Related Resources